The effect of immunosuppressive therapy on cardiac involvements in anti-mitochondrial antibody-positive myositis.

Satoshi BujoEisuke AmiyaMeiko Hashimoto MaedaJunichi IshidaMasaru HatanoMasato IshizukaMasae UeharaTsukasa OshimaToshiya KojimaKoki NakanishiMasao DaimonJun ShimizuTatsushi TodaIssei Komuro

Published in: ESC heart failure (2022)

Cardiac involvement in AMA-positive myositis may worsen even with glucocorticoid monotherapy, and there might be some associations between the change of LV function and additional immunosuppressive therapy.

Keyphrases

left ventricular
interstitial lung disease
oxidative stress
stem cells
combination therapy
randomized controlled trial
systemic sclerosis
open label
mesenchymal stem cells
atrial fibrillation
idiopathic pulmonary fibrosis